FDA Approves Casgevy to Treat Beta-Thalassemia

WEDNESDAY, Jan. 17, 2024 -- After approving Casgevy (exagamglogene autotemcel) in December to treat sickle cell disease, the U.S. Food and Drug Administration announced Tuesday that the therapy has now been approved to treat patients older than 12...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news